Analisi tecnica: L’indice S&P CNX NIFTY è l’indice azionario indiano che raggruppa i 50 titoli a maggiore capitalizzazione del paese. L’indice presenta un andamento negativo iniziato in prossimità della maggiore resistenza posta a quota 6355.69 punti, corrispondente ai massimi storici……
Se vuoi ricevere le principali notizie riguardanti gli ETF e gli ETC iscriviti alla Nostra Newsletter settimanale gratuita. Clicca qui per iscriverti gratuitamente.
Day By Day – Indipendent Research
Previsioni:
Siamo positivi nel breve periodo e vediamo possibile un rally verso la resistenza posta a quota 5910 punti (precedente picco). Abbiamo impostato la soglia di invalidazione per questo scenario positivo leggermente al di sotto del supporto posto a 5600 punti.
| Prezzo di chiusura | 5926.9 |
| Visione a 2 mesi | NEUTRALE |
| Visione a 2 settimane | POSITIVO |
| Resistanze | 5910 / 6008 pts |
| Supporti | 5600 / 5435 pts |
L’analisi DBD Tracker datata 27/06/2011 consigliava l’acquisto dell’indice STOXX Europe 600 Health Care. Da allora, il nostro obiettivo finale posizionato a quota 411.17 punti è stato raggiunto, con una performance del 3.7 %.
DISCAIMER
This publication is solely intended as information and does not constitute any investment advice or an offer, solicitation or recommendation to acquire or dispose of any investment or to engage in any transaction. Althoughthis publicationis issued in good faith, no representation or warranty, express or implied, is or willbe made and no responsibility or liability is or willbe accepted by NYSE Euronext or by any of its officers, employees or agents in relation to the accuracy or completeness of this publicationand any such liability is expressly disclaimed.No information set out or referred to in this publicationshall form the basis of any contract. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by NYSE Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. NYSE Euronext encourages you to reach your own opinion as to whether investments are appropriate or relevant and recommends you not to make any decisions on the basis of the information contained in this publication before checking it, as you will bear full responsibility for any use that you make of it. Persons wishingto trade products available on NYSE Euronextmarkets or wishingto offer such products to third parties are advised, before doing so, to check their legal and regulatory position in the relevant territory and to understand the related risks. All proprietary rights and interest in or connected with this publicationare vested in NYSE Euronext.No part of it may be redistributed or reproduced in any form or by any means or used to make any derivative work (such as translation, transformation, or adaptation) without the prior written permission of NYSE Euronext. NYSE Euronext refers to NYSE Euronext and its affiliates and references to NYSE Euronext in this publication include each and any such company as the context dictates. NYSE EuronextSM, Euronext®, trackers®, are registered marks of NYSE Euronext.
Source: ETFWorld – Day By Day – Indipendent Research
